Evidence map›Paper›PMID 26949410›Full record

ArticleJournal of molecular and genetic medicine : an international journal of biomedical research2015

The Adeno-Associated Virus Genome Packaging Puzzle.

Chen Ling, Yuan Wang, Yuan Lu, Lina Wang, Giridhara R Jayandharan, George V Aslanidi, Baozheng Li, Binbin Cheng, Wenqin Ma, Thomas Lentz and 5 more

Abstract read
In one paragraph

Article in Journal of molecular and genetic medicine : an international journal of biomedical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Reply to "D" matters in recombinant AAV packaging.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors.Molecular therapy. Methods & clinical development · 2016
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Chen LingDivision of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, USA; Powell Gene Therapy Center, University of Florida College of Medicine, Gainesville, FL, USA.
Yuan WangDivision of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, USA; Powell Gene Therapy Center, University of Florida College of Medicine, Gainesville, FL, USA; Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China.
Yuan LuDepartment of Orthopedics & Rehabilitative Medicine, University of Florida College of Medicine, Gainesville, FL, USA.
Lina WangDivision of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, USA; Powell Gene Therapy Center, University of Florida College of Medicine, Gainesville, FL, USA; Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China.
Giridhara R JayandharanDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India.
George V AslanidiDivision of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, USA; Powell Gene Therapy Center, University of Florida College of Medicine, Gainesville, FL, USA.
Baozheng LiDivision of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, USA; Powell Gene Therapy Center, University of Florida College of Medicine, Gainesville, FL, USA.
Binbin ChengDivision of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, USA; Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China.
Wenqin MaDivision of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, USA; Powell Gene Therapy Center, University of Florida College of Medicine, Gainesville, FL, USA.
Thomas LentzGene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Changquan LingDepartment of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China.
Xiao XiaoGene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Division of Molecular Pharmaceutics, University of North Carolina School of Pharmacy, Chapel Hill, NC, USA.
R Jude SamulskiGene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Nicholas MuzyczkaPowell Gene Therapy Center, University of Florida College of Medicine, Gainesville, FL, USA; Department of Molecular Genetics & Microbiology, University of Florida College of Medicine, Gainesville, FL, USA; Genetics Institute, University of Florida College of Medicine, Gainesville, FL, USA.
Arun SrivastavaDivision of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL, USA; Powell Gene Therapy Center, University of Florida College of Medicine, Gainesville, FL, USA; Department of Molecular Genetics & Microbiology, University of Florida College of Medicine, Gainesville, FL, USA; Genetics Institute, University of Florida College of Medicine, Gainesville, FL, USA; Shands Cancer Center, University of Florida College of Medicine, Gainesville, FL, USA.

Funding

Strategies for Sustained Effect of AAV-mediated Correction of Pompe DiseaseP01DK058327 · NIDDK · UNIVERSITY OF FLORIDA · PI BYRNE, BARRY J · 2000 to 2009
$11.0M
Next Generation of Recombinant AAV Serotype Vectors for Gene TherapyR01HL097088 · NHLBI · UNIVERSITY OF FLORIDA · PI GAO, GUANGPING, HERZOG, ROLAND W. · 2010 to 2018
$5.4M
The role of pH and protease activity in AAV viral transductionR01GM109524 · NIGMS · UNIVERSITY OF FLORIDA · PI AGBANDJE-MCKENNA, MAVIS, MCKENNA, ROBERT · 2014 to 2017
$2.0M
Safety and efficacy of optimized AAV3 vectors in murine and NHP liversR21EB015684 · NIBIB · UNIVERSITY OF FLORIDA · PI GAO, GUANGPING, SRIVASTAVA, ARUN · 2012 to 2013
$432k
NHLBI NIH HHS R01 HL097088NIBIB NIH HHS R21 EB015684NIDDK NIH HHS P01 DK058327NIGMS NIH HHS R01 GM109524
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID26949410
PMCPMC4778740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.